within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DC12_Cefminox;
model Cefminox 
   extends Pharmacolibrary.Drugs.ATC.J.J01DC12;

  annotation(Documentation(
    info ="<html><body><p>Cefminox is a second-generation cephalosporin antibiotic, used primarily in the treatment of bacterial infections, particularly those caused by Gram-negative and some Gram-positive organisms. It has been mainly used in East Asia and is not widely approved or used in Western countries today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single intravenous infusion; parameters may vary in patients with renal impairment.</p><h4>References</h4><ol><li><p>Omoto, S, &amp; Watanabe, S (1990). Efficacy of cefminox in the treatment of bacterial infections. <i>International journal of clinical pharmacology research</i> 10(6) 361–368. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2099361/&quot;>https://pubmed.ncbi.nlm.nih.gov/2099361</a></p></li><li><p>Azuma, Y, et al., &amp; Goi, H (1989). [Pharmacokinetics and antimicrobial effect of cefminox in serum and ascitic fluid for experimental purulent peritonitis in mice]. <i>Nihon geka hokan. Archiv fur japanische Chirurgie</i> 58(5) 445–451. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2701930/&quot;>https://pubmed.ncbi.nlm.nih.gov/2701930</a></p></li><li><p>Cho, N, et al., &amp; Fukunaga, K (1985). [Pharmacokinetics and clinical studies on cefminox in the field of obstetrics and gynecology]. <i>The Japanese journal of antibiotics</i> 38(5) 1213–1224. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3930789/&quot;>https://pubmed.ncbi.nlm.nih.gov/3930789</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Cefminox;
